• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Myb 表达的依赖性在具有 N 端 CEBPA 突变的髓性白血病中减弱。

Dependence on Myb expression is attenuated in myeloid leukaemia with N-terminal CEBPA mutations.

机构信息

Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK

Key Laboratory of Regenerative Biology, Joint School of Life Sciences, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, and Guangzhou Medical University, Guangzhou, China.

出版信息

Life Sci Alliance. 2019 Mar 15;2(2). doi: 10.26508/lsa.201800207. Print 2019 Apr.

DOI:10.26508/lsa.201800207
PMID:30877232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6421631/
Abstract

Mutations at the N- or C-terminus of C/EBPα are frequent in acute myeloid leukaemia (AML) with normal karyotype. Here, we investigate the role of the transcription factor Myb in AMLs driven by different combinations of CEBPA mutations. Using knockdown of Myb in murine cell lines modelling the spectrum of CEBPA mutations, we show that the effect of reduced Myb depends on the mutational status of the two Cebpa alleles. Importantly, Myb knockdown fails to override the block in myeloid differentiation in cells with biallelic N-terminal C/EBPα mutations, demonstrating for the first time that the dependency on Myb is much lower in AML with this mutational profile. By comparing gene expression following Myb knockdown and chromatin immunoprecipitation sequencing data for the binding of C/EBPα isoforms, we provide evidence for a functional cooperation between C/EBPα and Myb in the maintenance of AML. This co-dependency breaks down when both alleles of CEBPA harbour N-terminal mutations, as a subset of C/EBPα-regulated genes only bind the short p30 C/EBPα isoform and, unlike other C/EBPα-regulated genes, do so without a requirement for Myb.

摘要

CEBPA 基因 N 或 C 末端突变在核型正常的急性髓细胞白血病(AML)中很常见。在这里,我们研究了转录因子 Myb 在由不同 CEBPA 突变组合驱动的 AML 中的作用。通过在模拟 CEBPA 突变谱的小鼠细胞系中敲低 Myb,我们表明,Myb 减少的效果取决于两个 Cebpa 等位基因的突变状态。重要的是,Myb 敲低未能克服双等位基因 N 端 C/EBPα 突变细胞中髓系分化的阻滞,这首次证明在这种突变特征的 AML 中,对 Myb 的依赖性要低得多。通过比较 Myb 敲低后的基因表达和 C/EBPα 同工型结合的染色质免疫沉淀测序数据,我们提供了 C/EBPα 和 Myb 在维持 AML 中功能合作的证据。当 CEBPA 的两个等位基因都存在 N 端突变时,这种共同依赖性就会瓦解,因为一小部分 C/EBPα 调节基因只与短的 p30 C/EBPα 同工型结合,并且与其他 C/EBPα 调节基因不同,不需要 Myb。

相似文献

1
Dependence on Myb expression is attenuated in myeloid leukaemia with N-terminal CEBPA mutations.Myb 表达的依赖性在具有 N 端 CEBPA 突变的髓性白血病中减弱。
Life Sci Alliance. 2019 Mar 15;2(2). doi: 10.26508/lsa.201800207. Print 2019 Apr.
2
Identification of gene targets of mutant C/EBPα reveals a critical role for MSI2 in CEBPA-mutated AML.突变型C/EBPα基因靶点的鉴定揭示了MSI2在CEBPA突变型急性髓系白血病中的关键作用。
Leukemia. 2021 Sep;35(9):2526-2538. doi: 10.1038/s41375-021-01169-6. Epub 2021 Feb 23.
3
C/EBPα-p30 confers AML cell susceptibility to the terminal unfolded protein response and resistance to Venetoclax by activating DDIT3 transcription.C/EBPα-p30 通过激活 DDIT3 转录赋予 AML 细胞对末端未折叠蛋白反应的敏感性和对 Venetoclax 的耐药性。
J Exp Clin Cancer Res. 2024 Mar 13;43(1):79. doi: 10.1186/s13046-024-02975-3.
4
The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression.急性髓系白血病中的N端CEBPA突变体损害CXCR4表达。
Haematologica. 2014 Dec;99(12):1799-807. doi: 10.3324/haematol.2014.107821. Epub 2014 Sep 5.
5
C/EBPα and MYB regulate FLT3 expression in AML.C/EBPα 和 MYB 调节 AML 中的 FLT3 表达。
Leukemia. 2013 Jul;27(7):1487-96. doi: 10.1038/leu.2013.23. Epub 2013 Jan 23.
6
Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia.来那度胺介导的 C/EBPα-p30 蛋白翻译增强上调急性髓系白血病中的抗白血病 microRNA-181a 的表达。
Blood. 2013 Jan 3;121(1):159-69. doi: 10.1182/blood-2012-05-428573. Epub 2012 Oct 25.
7
mutants down-regulate AML cell susceptibility to NK-mediated lysis by disruption of the expression of NKG2D ligands, which can be restored by LSD1 inhibition.突变体通过破坏NKG2D配体的表达来下调AML细胞对NK介导的裂解的敏感性,而这种敏感性可通过抑制LSD1得以恢复。
Oncoimmunology. 2022 Jan 5;11(1):2016158. doi: 10.1080/2162402X.2021.2016158. eCollection 2022.
8
C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations.C/EBPα 调节的 microRNA-34a 在粒细胞生成过程中靶向 E2F3,并且在具有 CEBPA 突变的 AML 中下调。
Blood. 2010 Dec 16;116(25):5638-49. doi: 10.1182/blood-2010-04-281600. Epub 2010 Oct 1.
9
The +37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBPα, PU.1, and Additional Ets Factors.+37 kb 的 Cebpa 增强子对 Cebpa 髓系基因表达至关重要,且包含与 SCL、GATA2、C/EBPα、PU.1 及其他 Ets 因子结合的功能位点。
PLoS One. 2015 May 4;10(5):e0126385. doi: 10.1371/journal.pone.0126385. eCollection 2015.
10
Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia.C/EBPα N端白血病中Wdr5-MLL相互作用的药理学靶向作用
Nat Chem Biol. 2015 Aug;11(8):571-578. doi: 10.1038/nchembio.1859. Epub 2015 Jul 13.

引用本文的文献

1
Gene expression profiling and pathway analysis in acute myeloid leukaemia-normal karyotype patients.急性髓系白血病正常核型患者的基因表达谱分析及通路分析
PLoS One. 2025 Sep 5;20(9):e0328911. doi: 10.1371/journal.pone.0328911. eCollection 2025.
2
MAFB: a key regulator of myeloid commitment involved in hematological diseases.MAFB:参与血液系统疾病的髓系定向分化关键调节因子。
Cell Death Discov. 2025 Jun 12;11(1):276. doi: 10.1038/s41420-025-02551-4.
3
Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML.

本文引用的文献

1
CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex.CEBPA 突变型白血病对 MLL1 复合物的遗传和药理学靶向治疗敏感。
Leukemia. 2019 Jul;33(7):1608-1619. doi: 10.1038/s41375-019-0382-3. Epub 2019 Jan 24.
2
MYBL2 Supports DNA Double Strand Break Repair in Hematopoietic Stem Cells.MYBL2 在造血干细胞中支持 DNA 双链断裂修复。
Cancer Res. 2018 Oct 15;78(20):5767-5779. doi: 10.1158/0008-5472.CAN-18-0273. Epub 2018 Aug 6.
3
Prognostic significance of high GFI1 expression in AML of normal karyotype and its association with a FLT3-ITD signature.
MYB 依赖性抑制 MAFB 表达的逆转消除了 MLL 重排 AML 中的白血病表型。
Cell Death Dis. 2023 Nov 23;14(11):763. doi: 10.1038/s41419-023-06276-z.
4
The AML-associated K313 mutation enhances C/EBPα activity by leading to C/EBPα overexpression.AML 相关的 K313 突变通过导致 C/EBPα 过表达增强 C/EBPα 的活性。
Cell Death Dis. 2021 Jul 5;12(7):675. doi: 10.1038/s41419-021-03948-6.
5
Menin is necessary for long term maintenance of meningioma-1 driven leukemia.Menin 对于脑膜瘤-1 驱动的白血病的长期维持是必要的。
Leukemia. 2021 May;35(5):1405-1417. doi: 10.1038/s41375-021-01146-z. Epub 2021 Feb 4.
6
Gain-of-Function Effects of N-Terminal CEBPA Mutations in Acute Myeloid Leukemia.CEBPA 基因突变的 N 端在急性髓细胞白血病中的功能获得效应。
Bioessays. 2020 Feb;42(2):e1900178. doi: 10.1002/bies.201900178. Epub 2019 Dec 23.
高 GFI1 表达在正常核型 AML 中的预后意义及其与 FLT3-ITD 特征的关联。
Sci Rep. 2017 Sep 11;7(1):11148. doi: 10.1038/s41598-017-11718-8.
4
Transcriptional regulation of SPROUTY2 by MYB influences myeloid cell proliferation and stem cell properties by enhancing responsiveness to IL-3.MYB对SPROUTY2的转录调控通过增强对IL-3的反应性影响髓样细胞增殖和干细胞特性。
Leukemia. 2017 Apr;31(4):957-966. doi: 10.1038/leu.2016.289. Epub 2016 Oct 17.
5
Dynamic Gene Regulatory Networks Drive Hematopoietic Specification and Differentiation.动态基因调控网络驱动造血细胞特化与分化。
Dev Cell. 2016 Mar 7;36(5):572-87. doi: 10.1016/j.devcel.2016.01.024. Epub 2016 Feb 25.
6
Lineage-specific enhancers activate self-renewal genes in macrophages and embryonic stem cells.谱系特异性增强子在巨噬细胞和胚胎干细胞中激活自我更新基因。
Science. 2016 Feb 12;351(6274):aad5510. doi: 10.1126/science.aad5510. Epub 2016 Jan 21.
7
Regulation of the Flt3 Gene in Haematopoietic Stem and Early Progenitor Cells.造血干细胞和早期祖细胞中Flt3基因的调控
PLoS One. 2015 Sep 18;10(9):e0138257. doi: 10.1371/journal.pone.0138257. eCollection 2015.
8
Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia.C/EBPα N端白血病中Wdr5-MLL相互作用的药理学靶向作用
Nat Chem Biol. 2015 Aug;11(8):571-578. doi: 10.1038/nchembio.1859. Epub 2015 Jul 13.
9
BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia.BET溴结构域抑制可抑制急性髓系白血病中造血转录因子的功能。
Mol Cell. 2015 Jun 18;58(6):1028-39. doi: 10.1016/j.molcel.2015.04.011. Epub 2015 May 14.
10
Regulation of the C/EBPα signaling pathway in acute myeloid leukemia (Review).急性髓系白血病中C/EBPα信号通路的调控(综述)
Oncol Rep. 2015 May;33(5):2099-106. doi: 10.3892/or.2015.3848. Epub 2015 Mar 10.